M22
Payments companies reported to CMS as associated with M22. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with M22, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with M22
These are the largest totals companies reported as associated with M22. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Celesta Ribas Ferreira | Cypress, TX | Optometrist | $127,918.45 |
| Michael Mirmanesh | Pinellas Park, FL | Plastic Surgery | $87,961.17 |
| Amy Lewis | New York, NY | Dermatology | $79,812.92 |
| Richard Adler | Baltimore, MD | Ophthalmology | $72,200.00 |
| James Chelnis | New York, NY | Ophthalmic Plastic and Reconstructive Surgery | $67,469.52 |
| Shauna Diggs | Grosse Pointe, MI | Dermatology | $63,372.81 |
| Holly Pelletier | Manchester, NH | Medical | $54,228.42 |
| Brittany Yates | Tallahassee, FL | Family | $50,894.52 |
| Ryan Gustus | Bluffton, IN | Optometrist | $40,075.26 |
| Nishi Mehdiratta | Houston, TX | Optometrist | $37,474.99 |
Prescribed M22?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.